CRESCENT BIOPHARMA, INC. - CBIO
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | BALYASNY ASSET MANAGEMENT L.P. | 6.03% | 1,662,917 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BAM GP LLC | 6.03% | 1,662,917 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Balyasny Asset Management Holdings LP | 6.03% | 1,662,917 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Dames GP LLC | 6.03% | 1,662,917 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Dmitry Balyasny | 6.03% | 1,662,917 | View |
| Jul 20, 2026 | SCHEDULE 13D/A | — | 19.99% | — | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL MANAGEMENT, LLC | 4.21% | 1,160,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | KEVIN TANG | 4.21% | 1,160,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS, LP | 2.24% | 616,477 | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 1.64% | 451,619 | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS III, INC | 0.33% | 91,904 | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G | Balyasny Asset Management L.P. | 5.48% | 1,510,033 | View |
| May 15, 2026 | SCHEDULE 13G | BAM GP LLC | 5.48% | 1,510,033 | View |
| May 15, 2026 | SCHEDULE 13G | Balyasny Asset Management Holdings LP | 5.48% | 1,510,033 | View |
| May 15, 2026 | SCHEDULE 13G | Dames GP LLC | 5.48% | 1,510,033 | View |
| May 15, 2026 | SCHEDULE 13G | Dmitry Balyasny | 5.48% | 1,510,033 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.